Mid-Year Report
FOLEY HOAG LLP for ASTRAZENECA PHARMACEUTICALS LP
Firm
Income
$120,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Patent Reform, S 1145, HR 1908
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS GRISSOM | N/A |
| PAUL KIM | N/A |
| DAVID MOHLER | N/A |
Health Issues HCR
Pharmaceutical Legislation Food and Drug Administration, S 1082, HR 2900 Follow-on Biologics, S 1695
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS GRISSOM | N/A |
| PAUL KIM | N/A |
| DAVID MOHLER | N/A |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.